Write for four readers (development scientists, CMC leads, sourcing and quality) in five formats (application notes, case summaries, method explainers, regulatory explainers, recorded technical talks). Put a named scientist on every piece, have quality check the regulatory words, write an AI policy and keep a person on every fact, publish on your own site first, and count the inquiries and shortlists each piece starts.
Fewer, correct pieces beat more, faster ones in this industry.
Who reads it, and what each reader wants
Four readers, four questions:
- Development scientists: how a problem was solved, with the method and the data that matter.
- CMC and technical leads: whether your capability fits their molecule, phase and regulatory path.
- Sourcing and external manufacturing: capacity, sites, timelines, quality history and who they would work with.
- Quality and regulatory: exact statements about registrations, DMFs, CEPs, GMP and inspections.
Five formats that earn trust
Application notes describe a specific technical result: a crystallization made reliable, a solubility problem solved, an impurity controlled, with the method and enough data to be credible.
Case summaries tell a project story without the sponsor's name unless permission is on file: the starting point, the problem, what your team did and what changed.
Method explainers describe an analytical or process capability and when a sponsor would need it.
Regulatory explainers help sponsors understand a requirement that affects them, written carefully and reviewed by your regulatory team.
Recorded technical talks let a scientist walk through a topic in their own words; publish them with a transcript so they can be read and found.
The review process that keeps it correct
Each piece has a named scientist as author or reviewer, a quality or regulatory check on every statement about registrations, filings, inspections and GMP, and a final read for anything that names a sponsor. The regulatory words follow the rules in our pillar: under 21 CFR 207.77, registration does not denote approval, so "FDA-approved facility" never appears. Google's helpful content guidance asks whether a page shows first-hand expertise and makes clear who created it; a scientist's name and role on the page answers both.
Speed is the wrong target
CMI's 2027 B2B content research found that 65% of B2B marketers faced more pressure to produce content faster in the past 12 months, and that 40% are spending more on owned media. In life sciences the useful lesson is the second one: invest in your own site and library. The first is a trap, because one technical error read by a sponsor's scientist costs more trust than a month of silence. Plan a steady rate your scientists can review properly, and keep it.
AI in drafting, with a policy
The same research found AI agent use among B2B marketers more than doubled to 59%, while 52% say their organization has no policy on disclosing AI use and only 8% disclose it on every piece. For a life science supplier, write a short policy before using AI tools: what they may draft, which facts a person must verify from the source, what is never generated (data, regulatory statements, sponsor details), and whether and how you disclose AI assistance. A hallucinated figure in a technical note is read by buyers as a verdict on your science.
Publish on your own site first
Publish every piece on your own site, organized by capability and modality, then share it. Google's guidance on AI features says the usual SEO practices remain relevant for AI Overviews and AI Mode, with no additional requirements, and Pew Research Center found in March 2025 that users who saw an AI summary clicked a traditional result 8% of the time, against 15% without one, as its report describes. Specific, first-hand technical pages are the kind that get cited. Our guide to life science SEO covers how those pages are found.
Distribution: consented email and LinkedIn
Send new content to people who have agreed to receive it: in the USA the FTC's CAN-SPAM guide requires accurate headers, a postal address and an opt-out honored within 10 business days, with penalties up to $53,088 per email, and in Canada CASL requires consent before a commercial electronic message. On LinkedIn, put pieces in front of the roles that build long lists; its ad targeting reaches members by job title, company, industry and seniority. Your scientists sharing their own work on their profiles often reaches further than the company page.
Reuse in proposals and visits
The same library feeds RFP responses, capability presentations and site-visit packs. Approved application notes and case summaries become proof sections in a proposal; scientist profiles become the team section. Our guide to the CDMO RFP covers how the library speeds up responses.
How to measure it
By piece and by quarter: inquiries that name or follow a piece, sample or capability requests, appearances on sponsor short lists you can trace, content used in proposals, and the search queries each piece is found for. Views, likes and downloads are context. Retire or update pieces that no longer reflect your capability.
If you want it planned with you
PromotEdge International is an international strategy, technology, marketing and design company, and our delivery team is in India. Life science clients we have worked for include Kopran and Novozymes. That work was for their business in India and was delivered by our team there. Our life science marketing service page and our content marketing page describe the work. This guide is general information, not legal or regulatory advice.
Facts we rely on: see our company facts for what we state about ourselves and where each fact comes from.